Disclosures: Taotao Yan: Nothing to Disclose, Nicholas Chien: Nothing to Disclose, Ashley Fong: Nothing to Disclose, Vy Nguyen: Nothing to Disclose, Isaac Le: Nothing to Disclose, Annie Fung: Nothing to Disclose, Surya Teja Gudapati: Nothing to Disclose, Sally Tran: Nothing to Disclose, Angela Chau: Nothing to Disclose, Xinrong Zhang: Nothing to Disclose, Jung Eun Park: Nothing to Disclose, Ramsey Cheung: Nothing to Disclose, Changqing Zhao: Nothing to Disclose, Mingjuan Jin: Nothing to Disclose 1181 SUBOPTIMAL DIAGNOSIS RATE AND PERI-COMPLICATION DIAGNOSIS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN THE U.S.: A POPULATION-BASED STUDY Vy Nguyen 1 Scott Barnett 1 Xinrong Zhang 1 Ramsey Cheung 2 Mindie Nguyen 2 , 1 Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA, 2 Stanford University Medical Center Background: The incidence of MASLD is estimated to affect over half of the global adult population by 2040, yet disease awareness remains low in the U.S
Artificial intelligence-driven platforms merging metagenomic, metabolomic, and clinical data may predict patient-specific ICI responses
ATMC recognizes this potential risk and treats it with safe and gentle neurotoxin removal techniques
When B12 is taken multiple times throughout the day, 2-5 g of B12 per intake can be sufficient
Scicom J Med Appl Med Sci
